This pattern of FCRL2 expression was in contrast to CD38, ZAP-70, and CD49d, which are chiefly upregulated in patients with unmutated CLL who experience a more aggressive disease course (10, 36, 37). The gene discussed is FCRL2; the disease is B-cell chronic lymphocytic leukemia.